Guo T Z, Davies M F, Kingery W S, Patterson A J, Limbird L E, Maze M
Department of Anesthesia, Stanford Univeristy, California, USA.
Anesthesiology. 1999 Feb;90(2):470-6. doi: 10.1097/00000542-199902000-00022.
Opiate receptors in the periaqueductal gray region and alpha2 adrenoceptors in the spinal cord of the rat mediate the antinociceptive properties of nitrous oxide (N2O). The availability of genetically altered mice facilitates the detection of the precise protein species involved in the transduction pathway. In this study, the authors establish the similarity between rats and mice in the antinociceptive action of N2O and investigate which alpha2 adrenoceptor subtypes mediate this response.
After obtaining institutional approval, antinociceptive dose-response and time-course to N2O was measured in wild-type and transgenic mice (D79N), with a nonfunctional alpha2A adrenoceptor using tail-flick latency. The antinociceptive effect of N2O was tested after pretreatment systemically with yohimbine (nonselective alpha2 antagonist), naloxone (opiate antagonist), L659,066 (peripheral alpha2-antagonist) and prazosin (alpha2B- and alpha2C-selective antagonist). The tail-flick latency to dexmedetomidine (D-med), a nonselective alpha2 agonist, was tested in wild-type and transgenic mice.
N2O produced antinociception in both D79N transgenic and wild-type litter mates, although the response was less pronounced in the transgenic mice. Antinociception from N2O decreased over time with continuing exposure, and the decrement was more pronounced in the transgenic mice. The antinociceptive response could be dose dependently antagonized by opiate receptor and selective alpha2B-/alpha2C-receptor antagonists but not by a central nervous system-impermeant alpha2 antagonist (L659,066). Whereas dexmedetomidine exhibited no antinociceptive response in the D79N mice, the robust antinociceptive response in the wild-type litter mates could not be blocked by a selective alpha2B-/alpha2C-receptor antagonist.
These data confirm that the antinociceptive response to an exogenous alpha2-agonist is mediated by an alpha2A adrenoceptor and that there appears to be a role for the alpha2B- or alpha2C-adrenoceptor subtypes, or both, in the analgesic response to N2O.
大鼠中脑导水管周围灰质区域的阿片受体和脊髓中的α2肾上腺素能受体介导一氧化二氮(N2O)的镇痛特性。基因工程改造小鼠的出现有助于检测参与转导途径的精确蛋白质种类。在本研究中,作者确定了大鼠和小鼠在N2O镇痛作用方面的相似性,并研究了哪些α2肾上腺素能受体亚型介导了这种反应。
获得机构批准后,使用甩尾潜伏期测量野生型和转基因小鼠(D79N,其α2A肾上腺素能受体无功能)对N2O的镇痛剂量反应和时程。在全身预先用育亨宾(非选择性α2拮抗剂)、纳洛酮(阿片拮抗剂)、L659,066(外周α2拮抗剂)和哌唑嗪(α2B和α2C选择性拮抗剂)预处理后,测试N2O的镇痛效果。在野生型和转基因小鼠中测试了右美托咪定(D-med,一种非选择性α2激动剂)的甩尾潜伏期。
N2O在D79N转基因小鼠和野生型同窝小鼠中均产生了镇痛作用,尽管转基因小鼠中的反应不太明显。随着持续暴露,N2O的镇痛作用随时间下降,且转基因小鼠中的下降更为明显。阿片受体和选择性α2B/α2C受体拮抗剂可剂量依赖性地拮抗镇痛反应,但中枢神经系统不透性的α2拮抗剂(L659,066)则不能。虽然右美托咪定在D79N小鼠中未表现出镇痛反应,但野生型同窝小鼠中强烈的镇痛反应不能被选择性α2B/α2C受体拮抗剂阻断。
这些数据证实,对外源性α2激动剂的镇痛反应由α2A肾上腺素能受体介导,并且α2B或α2C肾上腺素能受体亚型或两者在对N2O的镇痛反应中似乎起作用。